Media coverage about Wright Medical Group (NASDAQ:WMGI) has been trending positive this week, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Wright Medical Group earned a media sentiment score of 0.42 on Accern’s scale. Accern also gave press coverage about the medical device company an impact score of 47.0961053611705 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media headlines that may have impacted Accern’s rankings:
- Contrasting Wright Medical Group (WMGI) and Its Peers (americanbankingnews.com)
- Reviewing Wright Medical Group (WMGI) and The Competition (americanbankingnews.com)
- Wright Medical Group’s (WMGI) “Buy” Rating Reaffirmed at Royal Bank of Canada (americanbankingnews.com)
- Wright Medical Group (WMGI) Upgraded to “Sell” by BidaskClub (americanbankingnews.com)
- Analysts Anticipate Wright Medical Group Inc (WMGI) Will Post Quarterly Sales of $193.49 Million (americanbankingnews.com)
WMGI has been the topic of several recent analyst reports. BidaskClub lowered shares of Wright Medical Group from a “sell” rating to a “strong sell” rating in a report on Wednesday, February 21st. TheStreet lowered shares of Wright Medical Group from a “c-” rating to a “d+” rating in a report on Wednesday, December 27th. Oppenheimer set a $25.00 target price on shares of Wright Medical Group and gave the company a “hold” rating in a report on Wednesday, February 28th. Cantor Fitzgerald set a $30.00 target price on shares of Wright Medical Group and gave the company a “buy” rating in a report on Monday, January 8th. Finally, ValuEngine lowered shares of Wright Medical Group from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $29.38.
Wright Medical Group (NASDAQ:WMGI) last posted its quarterly earnings results on Tuesday, February 27th. The medical device company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.06. Wright Medical Group had a negative net margin of 27.19% and a negative return on equity of 3.78%. The company had revenue of $217.60 million for the quarter, compared to the consensus estimate of $215.69 million. analysts expect that Wright Medical Group will post -0.18 earnings per share for the current year.
WARNING: This piece of content was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3342618/wright-medical-group-wmgi-given-news-sentiment-rating-of-0-42.html.
About Wright Medical Group
Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.